Sarah J Pirrie (Sarah Pirrie)
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 5
Publications (10 Years): 5
University Of Birmingham
Affiliation History
University Of Birmingham
Aug 06 2006
United Kingdom
Publications
- Nicholas D James, Wenyu Liu, Sarah J Pirrie, Baljit Kaur, Carey Hendron, Daniel Ford, Anjali Zarkar, Richard Viney, Elizabeth Southgate, Amisha Desai, Syed A Hussain, null null
- Nicholas D James, Ayesha Ali, Ann Pope, Amisha Desai, Daniel Ford, Robert Stevenson, Anjali Zarkar, Sarah J Pirrie, null null
- Stelios Chrysostomou, Rajat Roy, Filippo Prischi, Lucksamon Thamlikitkul, Kathryn L Chapman, Uwais Mufti, Robert L Peach, Laifeng Ding, David C Hancock, Christopher Moore, Miriam Molina-Arcas, Francesco Mauri, David James Pinato, Joel M Abrahams, Silvia Ottaviani, Castellano L, Georgios Giamas, Jennifer Pascoe, Devmini Moonamale, Sarah J Pirrie, Claire Gaunt, Lucinda Billingham, Neil M Steven, Michael Cullen, David Hrouda, Mathias Winkler, John Post, Philip Cohen, Seth J Salpeter, Vered Bar, Adi Zundelevich, Shay Golan, Dan Leibovici, Romain Lara, David R Klug, Sophia N Yaliraki, Mauricio Barahona, Yulan Wang, Julian Downward, J Mark Skehel, Maruf M U Ali, Michael J Seckl, Olivier E Pardo
- Adam Gibb, Sarah J Pirrie, Kim M Linton, Victoria Warbey, Kathryn Paterson, Andrew John Davies, Graham P Collins, Tobias Menne, Pamela McKay, Paul A Fields, Fiona M Miall, Eszter Nagy, Keith Wheatley, Rachel Reed, Ivona Baricevic-Jones, Sally F Barrington, John RadfordResults of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY). British journal of haematology 193 (1) (2020)